These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A DNA vaccine encoding the E protein of West Nile virus is protective and can be boosted by recombinant domain DIII. Schneeweiss A, Chabierski S, Salomo M, Delaroque N, Al-Robaiy S, Grunwald T, Bürki K, Liebert UG, Ulbert S. Vaccine; 2011 Aug 26; 29(37):6352-7. PubMed ID: 21596075 [Abstract] [Full Text] [Related]
6. Mapping and analysis of West Nile virus-specific monoclonal antibodies: prospects for vaccine development. Throsby M, Ter Meulen J, Geuijen C, Goudsmit J, de Kruif J. Expert Rev Vaccines; 2007 Apr 26; 6(2):183-91. PubMed ID: 17408368 [Abstract] [Full Text] [Related]
8. A recombinant envelope protein vaccine against West Nile virus. Ledizet M, Kar K, Foellmer HG, Wang T, Bushmich SL, Anderson JF, Fikrig E, Koski RA. Vaccine; 2005 Jun 10; 23(30):3915-24. PubMed ID: 15917113 [Abstract] [Full Text] [Related]
12. Vero cell-derived inactivated West Nile (WN) vaccine induces protective immunity against lethal WN virus infection in mice and shows a facilitated neutralizing antibody response in mice previously immunized with Japanese encephalitis vaccine. Lim CK, Takasaki T, Kotaki A, Kurane I. Virology; 2008 Apr 25; 374(1):60-70. PubMed ID: 18221765 [Abstract] [Full Text] [Related]
14. Immunogenicity and protective efficacy of recombinant Modified Vaccinia virus Ankara candidate vaccines delivering West Nile virus envelope antigens. Volz A, Lim S, Kaserer M, Lülf A, Marr L, Jany S, Deeg CA, Pijlman GP, Koraka P, Osterhaus AD, Martina BE, Sutter G. Vaccine; 2016 Apr 07; 34(16):1915-26. PubMed ID: 26939903 [Abstract] [Full Text] [Related]
16. A plant-produced vaccine protects mice against lethal West Nile virus infection without enhancing Zika or dengue virus infectivity. Lai H, Paul AM, Sun H, He J, Yang M, Bai F, Chen Q. Vaccine; 2018 Mar 27; 36(14):1846-1852. PubMed ID: 29490880 [Abstract] [Full Text] [Related]
20. A VLP-based vaccine targeting domain III of the West Nile virus E protein protects from lethal infection in mice. Spohn G, Jennings GT, Martina BE, Keller I, Beck M, Pumpens P, Osterhaus AD, Bachmann MF. Virol J; 2010 Jul 06; 7():146. PubMed ID: 20604940 [Abstract] [Full Text] [Related] Page: [Next] [New Search]